ViroGates A/S
CSE:VIRO
Operating Margin
ViroGates A/S
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
DK |
V
|
ViroGates A/S
CSE:VIRO
|
76.9m DKK |
-278%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
229.2B USD |
18%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.1B USD |
29%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
152.7B USD |
19%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
146B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
119.2B USD |
20%
|
|
CN |
H
|
Hongchang International Co Ltd
OTC:HCIL
|
103.8m USD |
-6%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.8B EUR |
14%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
56.2B USD |
13%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.2B USD |
31%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.9B USD |
28%
|
ViroGates A/S
Glance View
ViroGates A/S develops and markets prognostic products for the healthcare sector. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on ViroGates A/S's most recent financial statements, the company has Operating Margin of -277.6%.